Measuring Exhaled Nitric Oxide Does Not Improve Asthma Control
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Measuring Exhaled Nitric Oxide Does Not Improve Asthma Control

NEW YORK -- September 18, 2008 -- Measuring exhaled nitric oxide (NO) fractions from the breath of asthma patients does not clinically improve asthma control when combined with conventional management assessing symptoms and lung function, according to a study published in the Asthma Special Issue of The Lancet.

Stanley J. Szefler, MD, National Jewish Health, Denver, Colorado, and colleagues from the National Institute of Allergy and Infectious Diseases, National Institutes of Health Inner City Asthma Consortium, Bethesda, Maryland, conducted a randomised controlled trial in patients aged 12 to 20 years who were randomly assigned to a 46-week treatment period of either conventional management (control) or conventional management plus NO monitoring.

The researchers found that the number of days with asthma symptoms did not differ between groups, nor did lung function or worsening of asthma symptoms. However, patients in the NO monitoring group received higher doses of inhaled corticosteroids -- around 28% higher than controls (550 vs 431 mcg/day).

"Conventional asthma management resulted in good control of symptoms in most participants. The addition of fraction of exhaled NO as an indicator of control of asthma resulted in higher doses of inhaled corticosteroids, without clinically important improvements in symptomatic asthma control," the authors wrote.

In an accompanying comment, Søren Pedersen, MD, Kolding Hospital, Kolding, Denmark, and Paul O'Byrne, MD, McMaster University, Hamilton, Ontario said: "More studies are needed to explore the usefulness of exhaled nitric oxide in subgroups of patients with asthma and its treatment-saving potential. Until such data are available, a recommendation to use exhaled nitric oxide measurements routinely in patients treated according to guidelines is not ready to be made yet."

SOURCE: The Lancet

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities